Hamulakova_2012_Eur.J.Med.Chem_55_23

Reference

Title : Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease - Hamulakova_2012_Eur.J.Med.Chem_55_23
Author(s) : Hamulakova S , Janovec L , Hrabinova M , Kristian P , Kuca K , Banasova M , Imrich J
Ref : Eur Journal of Medicinal Chemistry , 55 :23 , 2012
Abstract :

New tacrine derivatives 5a-d 6a-d with piperazino-ethyl spacer linked with corresponding secondary amines and tacrine homodimer 8 were synthesized and tested as cholinesterase inhibitors on human acetylcholinesterase hAChE and human plasmatic butyrylcholinesterase hBChE In most cases the majority of synthesized derivatives exhibit a high AChE and BChE inhibitory activity with IC(50 values in the low-nanomolar range being clearly more potent than the reference standard tacrine 9-amino-1,2,3,4-tetrahydroacridine 1 and 7-MEOTA 7-methoxy-9-amino-1,2,3,4-tetrahydroacridine Among them inhibitors 8 and 5c showed a strong inhibitory activity against hAChE with an IC(50 value of 4.49 nM and 4.97 nM resp and a high selectivity to hAChE The compound 5d acted as the most potent inhibitor against hBChE with an IC(50 value of 33.7 nM and exhibited also a good selectivity towards hBChE The dissociation constants K(i of the selected inhibitors were compared with their IC(50 values Molecular modeling studies were performed to predict the binding modes between individual derivatives and hAChE/hBChE.

PubMedSearch : Hamulakova_2012_Eur.J.Med.Chem_55_23
PubMedID: 22818849

Related information

Citations formats

Hamulakova S, Janovec L, Hrabinova M, Kristian P, Kuca K, Banasova M, Imrich J (2012)
Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease
Eur Journal of Medicinal Chemistry 55 :23

Hamulakova S, Janovec L, Hrabinova M, Kristian P, Kuca K, Banasova M, Imrich J (2012)
Eur Journal of Medicinal Chemistry 55 :23